Last updated: 17 July 2019 at 8:32am EST

Felix Theeuwes Net Worth




The estimated Net Worth of Felix Theeuwes is at least $22.2 Milion dollars as of 26 April 2016. Felix Theeuwes owns over 160,000 units of Inovio Pharmaceuticals Inc stock worth over $22,245,857 and over the last 21 years Felix sold INO stock worth over $0.

Felix Theeuwes INO stock SEC Form 4 insiders trading

Felix has made over 14 trades of the Inovio Pharmaceuticals Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Felix bought 160,000 units of INO stock worth $200,000 on 26 April 2016.

The largest trade Felix's ever made was buying 714,285 units of Inovio Pharmaceuticals Inc stock on 8 November 2013 worth over $999,999. On average, Felix trades about 45,717 units every 31 days since 2004. As of 26 April 2016 Felix still owns at least 3,396,314 units of Inovio Pharmaceuticals Inc stock.

You can see the complete history of Felix Theeuwes stock trades at the bottom of the page.



What's Felix Theeuwes's mailing address?

Felix's mailing address filed with the SEC is 10260 BUBB ROAD, , CUPERTINO, CA, 95014.

Insiders trading at Inovio Pharmaceuticals Inc

Over the last 19 years, insiders at Inovio Pharmaceuticals Inc have traded over $23,656,819 worth of Inovio Pharmaceuticals Inc stock and bought 1,958,377 units worth $5,174,071 . The most active insiders traders include Austin W & Greenhouse David..., Jong Joseph Kim oraz Felix Theeuwes. On average, Inovio Pharmaceuticals Inc executives and independent directors trade stock every 22 days with the average trade being worth of $745,390. The most recent stock trade was executed by Michael John Sumner on 30 June 2024, trading 2,917 units of INO stock currently worth $19,106.



What does Inovio Pharmaceuticals Inc do?

inovio is revolutionizing the fight against cancer and infectious diseases. our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. with an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. partners and collaborators include roche, medimmune, university of pennsylvania, darpa, drexel university, nih, hiv vaccines trial network, national cancer institute, u.s. military hiv research program, and university of manitoba. for more information, visit www.inovio.com.



Complete history of Felix Theeuwes stock trades at Durect Corp i Inovio Pharmaceuticals Inc

Osoba
Trans.
Transakcja
Łączna cena
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $200,000
26 Apr 2016
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $98,700
14 Mar 2016
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $372,240
9 Mar 2015
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $596,600
6 Mar 2015
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $72,700
21 Nov 2014
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $125,134
19 Nov 2014
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $999,999
8 Nov 2013
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $90,000
10 Sep 2013
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $28,750
9 Sep 2013
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $101,000
13 Nov 2012
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $27,650
14 May 2012
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $32,074
10 May 2012
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $52,930
10 May 2012
Felix Theeuwes
Prezes Zarządu i CSO
Kupować $34,330
9 May 2012


Inovio Pharmaceuticals Inc executives and stock owners

Inovio Pharmaceuticals Inc executives and other stock owners filed with the SEC include: